The American College of Physicians (ACP) is advising physicians to tell men between the ages of 50 and 69 of the limited benefits and potential harms of the prostate-specific antigen (PSA) test before they undergo screening, according to recommendations published April 9 in Annals of Internal Medicine.

COLUMBIA, Mo. – Cancer painfully ends more than 500,000 lives in the United States each year, according to the Centers for Disease Control and Prevention. The scientific crusade against cancer recently achieved a victory under the leadership of University of Missouri Curators’ Professor M. Frederick Hawthorne. Hawthorne’s team has developed a new form of radiation therapy that successfully put cancer into remission in mice. This innovative treatment produced none of the harmful side-effects of conventional chemo and radiation cancer therapies. Clinical trials in humans could begin soon after Hawthorne secures funding.

LOS ANGELES (April 1, 2013) A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and “grab” circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.

Researchers at Vanderbilt and Columbia Universities are working on a system to view and treat bladder tumors that could eventually make an uncomfortable procedure both more tolerable and easier to perform.

Clinical and commercial leaders from GE Healthcare and Dorcy Cancer Center at St. Mary-Corwin Medical Center in Pueblo, Colorado, joined together today for a special tour to honor the Center’s continuing innovation in cancer care.

There are currently 13.7 million cancer survivors in the U.S., and that number is expected to rise to 18 million by 2022, according to the American Association for Cancer Research’s “Annual Report on Cancer Survivorship in the United States.”

The conclusion of the National Lung Screening Trial in November 2011 has created a new patient population—high-risk current and former smokers potentially eligible for CT screening. A clinical crossroads published March 20 in Journal of the American Medical Association addressed key points to consider in the informed decision-making process, remaining questions and the potential benefit of software, such as computer-aided detection and volumetric measurement tools, in CT screening.

Chest x-rays coupled with computer-aided detection (CAD) technology may have a higher identification rate for actionable lung nodules in a lung cancer screening population than unaided x-rays, though the ultimate role of CAD chest radiography remains unclear, according to a study published March 20 in PLoS ONE.